2 Result: Biophytis
Biophytis Gains Momentum; bluebird bio Posts Mixed Results
August 08th, 2023
Shares of Biophytis S.A. (Nasdaq: BPTS) surged over 10% in pre-market trading as the company secured a favorable opinion from Belgian authorities for its groundbreaking SARA-31 program. This initiative marks the first-ever phase 3 study targ. Read more
Breaking: Novartis Q2 Earnings Beat; Sarconeos Deal Boosts Biophytis
July 18th, 2023
Shares of Novartis AG (NYSE: NVS) experienced a surge in premarket trading as the company surpassed expectations in its second-quarter 2023 financial report. The pharmaceutical giant reported core earnings per share (EPS) of $1.83 and sales . Read more
Want To Find Some News?
News By Industries
Recent Post
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026
Member Login